1. 2019
  2. The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

    Faict, S., Oudaert, I., D'Auria, L., Dehairs, J., Maes, K., Vlummens, P., Veirman, K. D., Bruyne, E. D., Fostier, K., Broek, I. V., Schots, R., Vanderkerken, K., Swinnen, J. V. & Menu, E., 20 Nov 2019, In : Cancers. 11, 12, 1823.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

    Maes, A., Maes, K., Vlummens, P., De Raeve, H., Devin, J., Szablewski, V., De Veirman, K., Menu, E., Moreaux, J., Vanderkerken, K. & De Bruyne, E., 18 Nov 2019, In : Blood Cancer Journal. 9, 12, 11 p., 87.

    Research output: Contribution to journalArticleResearchpeer-review

  4. AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma

    Yan, S., Vandewalle, N., De Beule, N., Faict, S., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 5 Nov 2019, In : Cancers. 11, 11, p. 1-17 17 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. A Niche-Dependent Myeloid Transcriptome Signature Defines Dormant Myeloma Cells

    Khoo, W. H., Ledergor, G., Weiner, A., Roden, D. L., Terry, R. L., McDonald, M. M., Chai, R. C., De Veirman, K., Owen, K. L., Opperman, K. S., Vandyke, K., Clark, J. R., Seckinger, A., Kovacic, N., Nguyen, A., Mohanty, S. T., Pettitt, J. A., Xiao, Y., Corr, A. P., Seeliger, C. & 14 othersNovotny, M., Lasken, R. S., Nguyen, T. V., Oyajobi, B. O., Aftab, D., Swarbrick, A., Parker, B., Hewett, D. R., Hose, D., Vanderkerken, K., Zannettino, A. C. W., Amit, I., Phan, T. G. & Croucher, P. I., 4 Jul 2019, In : Blood. 134, 1, p. 30-43 14 p.

    Research output: Contribution to journalArticleResearchpeer-review

  6. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

    Maes, A., Maes, K., De Raeve, H., De Smedt, E., Vlummens, P., Szablewski, V., Devin, J., Faict, S., De Veirman, K., Menu, E., Offner, F., Spaargaren, M., Moreaux, J., Vanderkerken, K., Van Valckenborgh, E. & De Bruyne, E., 11 Jun 2019, In : British Journal of Cancer. 120, 12, p. 1137-1146 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

    De Veirman, K., Menu, E., Maes, K., De Beule, N., De Smedt, E., Maes, A., Vlummens, P., Fostier, K., Kassambara, A., Moreaux, J., Van Ginderachter, J. A., De Bruyne, E., Vanderkerken, K. & Van Valckenborgh, E., 1 Feb 2019, In : Cancer Letters. 442, p. 233-241 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Targeting of the histone methyltransferases G9a and GLP in multiple myeloma

    De Smedt, E., Devin, J., Liu, H., Vlummens, P., Maes, K., Maes, A., De Veirman, K., Menu, E., Vanderkerken, K., Moreaux, J. & De Bruyne, E., 2019, In : Belgian Journal of Hematology. p. 52-52 1 p., PP17.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  9. The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma

    Vlummens, P., De Veirman, K., Menu, E., De Bruyne, E., Offner, F., Vanderkerken, K. & Maes, K., 2019, In : Frontiers in Genetics. 10, 11 p., 740.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  10. 2018
  11. The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response

    De Smedt, E., Lui, H., Maes, K., De Veirman, K., Menu, E., Vanderkerken, K. & De Bruyne, E., 11 Dec 2018, In : Frontiers in Oncology. 8, DEC, 18 p., 566.

    Research output: Contribution to journalScientific reviewResearchpeer-review

Previous 1 2 3 4 5 6 7 Next

ID: 196090